Skip to main content
Log in

Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in the human laryngeal malignant cell line HEp-2

  • Published:
Bioscience Reports

Abstract

In the presence of 3-isobutyi-l-methylxanthine, VIP produced a dose-related (3×10−9−10−7 M) increase (g-fold) in cAMP production in isolated HEp-2 cells incubated at 15°C in KRP buffer. Among the peptides structurally related to VIP, including secretin (10−7 M), pancreatic glucagon (10−6 M), PHI, somatostatin-14 (10−6 M), hpGRF (10−8−4×10−M), GIP (2×10−7 M), only PHI (3×10−7 M and above) is able to activate the cAMP-generating system in HEp-2 cells, but at 102 times lower potency. Under the same conditions, histamine (10−3 M) was also ineffective, while PGE 2 (10−7−10−4 M) increased (0-fold) basal cAMP levels in HEp-2 cells. The VIP effect is related to the interaction os the peptide on VIP recognition sites (12SI-VIP-binding capacity ), coupled to the membrane-bound adenylate cyclase . The results indicate that the transformed laryngeal cell line HEp-2 possessesa receptor-cAMP system preferentially activated by VIP (relative potencies: VIP > PHI ≫ other peptides of the secretin family), and suggest that this neuropeptide could modulate biological functions in normal laryngeal epithelia in man.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Said SI (1984) Peptides5, 143–150.

    Google Scholar 

  2. Laburthe M, Boissard C, Chevalier G, Zweibaum A & Rosselin G (1981) Regulatory Peptides2, 219–230.

    Google Scholar 

  3. Emami S, Gespach C, Forgue-Lafitte ME, Broer Y & Rosselin G (1983) Life Sci.33, 415–423.

    Google Scholar 

  4. Laburthe M, Rousset M, Chevalier G, Goissard C, Dupont C, Zweibaum A & Rosselin G (1980) Cancer Research40, 2529–2533.

    Google Scholar 

  5. Moore AEL, Sabachewsky L & Toolan HW (1955) Cancer Research15, 598–604.

    Google Scholar 

  6. Prost A, Emami S, Rosselin G & Gespach C (1984) Dig. Diseases and Sciences29, 66S.

  7. Broer Y, Fouchereau M & Rosselin G (1972). C.R. Acad. Sci. Paris275, (D) 619–622.

    Google Scholar 

  8. Rosselin G & Freychet P (1973) Biochim. Biophys. Acta304, 541–551.

    Google Scholar 

  9. Tatemoto K & Mutt V (1980) Nature5764, 417–418.

    Google Scholar 

  10. Christophe J, Chatelain P, Taton G, Delhaye M, Waelbroeck M & Robberecht P (1981) Peptides2, 253–258.

    Google Scholar 

  11. Robberecht P, Chatelain P, De Neef P, Camus JC, Waelbroeck M & Christophe J (1981) Biochim. Biophys. Acta678, 76–82.

    Google Scholar 

  12. Watling KJ & Dowling JE (1983) J. Neurochem.41, 1205–1213.

    Google Scholar 

  13. Gespach C, Hui Bon Hoa D & Rosselin G (1983) Endocrinology, 1597–1606.

  14. Christophe JP, Conlon TP & Gardner JD (1976) J. Biol. Chem.251, 4629–4634.

    Google Scholar 

  15. Gespach C, Emami S, Lhiaubet AM, Fournier A, St Pierre S, Rosselin G & Rostene W (1984) IRCS Med. Sci.12, 724–725.

    Google Scholar 

  16. Laburthe M, Amiranoff B, Boige N, Rouyer-Fessard C, Tatemoto K & Moroder L (1983) FEBS Lett.159, 89–92.

    Google Scholar 

  17. Laburthe M, Prieto JC, Amiranoff B, Dupont C, Hui Bon Hoa D & Rosselin G (1979) Eur J. Biochem.96, 239–248.

    Google Scholar 

  18. Gespach C, Bataille D, Dutrillaux MC & Rosselin G (1982) Biochim. Biophys. Acta720, 7–16.

    Google Scholar 

  19. Bataille D, Gespach C, Coudray AM and Rosselin G (1981) Biosci. Rep.1, 151–155.

    Google Scholar 

  20. Dubrasquet M, Bataille D & Gespach C (1982) Biosci. Rep.2, 391–395.

    Google Scholar 

  21. Bataille D, Tatemoto K, Gespach C, Jörnvall H, Rosselin G & Mutt V (1982) FEBS Lett.146, 79–86.

    Google Scholar 

  22. Depigny C, Lupo B, Kervran A & Bataille D (1984) Dig. Dis. Sciences29, 20S.

    Google Scholar 

  23. Dey RD, Shannon WA & Said SI (1981) Cell Tissue Res.220, 231–238.

    Google Scholar 

  24. Nathanson I, Widdicombe JH & Barnes PJ (1983) J. Appl. Physiol.55, 1844–1848.

    Google Scholar 

  25. Frandsen EK, Krishna GA & Said SI (1978) Brit. J. Pharmacol.62, 367–369.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prost, A., Emami, S., Rosselin, G. et al. Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in the human laryngeal malignant cell line HEp-2. Biosci Rep 4, 1045–1050 (1984). https://doi.org/10.1007/BF01116697

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01116697

Keywords

Navigation